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Abstract
I In nt tr ro od du uc ct ti io on n: :   Allium plants are an important part of the diet of many populations
and there is a long-held belief in their health-enhancing properties such as
cancer prevention. In this study, the anticancer and anti-inflammatory activities
of the aqueous extract of the Allium ascalonicum bulbs have been studied. 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: : The antiproliferative and anti-growth activity of the
aqueous extract of A. ascalonicum was examined in vitro on different tumor cell
lines. Furthermore, the acetic acid-induced vascular permeability as an in vivo
assay was used for studying anti-inflammatory activity of the extract.
R Re es su ul lt ts s: : The aqueous extract of A. ascalonicum had the most anti-growth activity
on the cancer cell lines; Jurkat and K562 against Wehi 164 with lower cytotoxic
preference. The extract also showed much less cytotoxicity against the normal
cell (HUVEC) line and significant anti-inflammatory activity in vivo.
C Co on nc cl lu us si io on ns s: : It is of interest that the extract of this plant has shown much less
cytotoxicity against the normal cell line, and, if this also occurs in vivo, the use
of this plant clinically for the treatment of cancer patients would have some
scientific support. The results of these assays indicated that A. ascalonicum can
be a candidate for prevention and treatment of many diseases related to
inflammation and malignancy. 
K Ke ey y   w wo or rd ds s: : Allium ascalonicum, anti-inflammatory, anticancer, LDH assay.
Introduction
Cancer is one of the most prevalent diseases worldwide, which is
a major public health issue in both developed and developing countries.
Because of the high demand for cancer drugs, the need to less side effects
products from natural sources and the constraints of present production
technologies for pharmaceuticals, attention has recently been focused on
investigation and screening of pharmaceutical anticancer compounds in
plants. Indeed, plants have a long history of use in the treatment of cancer
[1]. However, the undeniable role of diet containing plants should not be
disregarded in the prevention of many diseases such as cancer. 
Until recently, a number of biological active phytochemicals have been
identified in plant foods [2]. Plant-derived compounds have been also an
important source of several clinically useful anticancer agents, which
include vinblastine, vincristine, the camptothecin derivatives, topotecan
and irinotecan, etoposide, derived from epipodophyllotoxin, and paclitaxel
(taxol). Moreover, several promising new agents, including flavopiridol and
combretastatin A4 phosphate, are in clinical development based on
C Co or rr re es sp po on nd de en nc ce e   a au ut th ho or r: :   
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selective activity against cancer-related molecular
targets while some agents which failed in earlier
clinical studies have been noticed again [3].
Shallot (Allium ascalonicum) is a member of the
Liliaceae family, which has been used mainly as
a spice traditionally from the ancient times. It has
many different benefits including antibacterial and
anti-fungal  properties  [4,  5],  beneficial  hema  -
tological influences [6], antioxidant properties [7],
anti-Helicobacter pylori potential effect [8] and
peroxynitrite-scavenging capacity [9] which have
been studied until now. Besides, the chemical
composition of A. ascalonicum was analyzed by
other researchers, and some effective components
such as a mannose-specific lectin [10], an anti-
fungal peptide [11], new furostanol saponins [12],
selenium  and  sulfur  species  [13],  and  various
flavonol glucosides [14], inhibit proliferation and
growth of tumor cell lines as HeLa and MCF-7 cell
lines extract [15]. Cytotoxic effect of selenized
odorless garlic and shallot against human leukemia
cells (HL-60) [16], arresting cell cycle progression
and  inducing  apoptosis  in  human  cervical
carcinoma HeLa cells [17] have been identified and
isolated from it. 
The  aim  of  this  study  was  to  investigate
anticancer and anti-inflammatory activities of the
aqueous extract of A. ascalonicum which were
performed using in vitro three cancer cell lines and
an in vivo acetic acid-induced vascular permeability
assay in mice.
Material and methods
R Re ea ag ge en nt ts s
DMEM (Dulbeccos modified minimum essential
medium), RPMI 1640 (Life Technologies, Grand
Island, NY), fetal bovine serum (FBS), Trypan blue
0.4%  (Gibco,  New  York,  USA),  LDH  (Lactate
dehydrogenase)  cytotoxicity  assay  kit  (Roch
Chemical Co.), Penicillin/streptomycin, trypsin /EDTA
(Sigma Chemical Co.).
P Pl la an nt t   m ma at te er ri ia al l
The bulbs of A. ascalonicum were prepared from
local vegetable markets at Kermanshah (West of
Iran), and authenticated by one of the authors 
(Dr. Ali Mostafaie).
P Pr re ep pa ar ra at ti io on n   o of f   p pl la an nt t   e ex xt tr ra ac ct t
Preparation  of  the  aqueous  extract  of
A. ascalonicum was  performed  as  previously
described  [18].  In  brief,  the  bulbs  (1  kg)  were
grounded in a mortar with one liter of distilled
water and stirred overnight to complete extraction.
Then, it was filtrated through a cheese cloth and
centrifuged at 16000 xg and 4°C for 30 min. After
complete extracting by distilled water and drying
the extract by freeze dryer, it’s the yield of which
was about 27.4% as compared to original bulbs
weight. Before use, it was weighed and dissolved
in sterile phosphate buffered saline (PBS).
C Ce el ll l   c cu ul lt tu ur re e
The cancer cell lines including Wehi164 (mouse
fibrosarcoma cells), Jurkat (human–acute T-cell
leukemia) and K562 (human erythroleukemia), and
human umbilical vein endothelial cells (HUVEC) as
a normal cell line were purchased from the National
Cell Bank, Pasteur Institute of Iran.
Cell lines were seeded in 75-cm2 tissue culture
flasks and maintained in RPMI 1640 and Dulbecco’s
MEM supplemented with 10% heat-inactivated fetal
bovine serum, 50 U/ml penicillin and 50 µg/ml
streptomycin. The medium was renewed every two
days and the cell cultures were incubated at 37°C
in a humidified atmosphere (95% air and 5% CO2).
C Ce el ll l   v vi ia ab bi il li it ty y   i in nh hi ib bi it ti io on n   a as ss sa ay ys s
Cytotoxicity  effects  on  cancer  cell  lines  by
A. asca  lonicum were evaluated by Trypan blue
exclusion assay and activity of lactate dehy  dro  -
genase (LDH) method.
T Tr ry yp pa an n   b bl lu ue e   a as ss sa ay y
Cancer cell lines at a density of 5 ￗ 104 per well
were seeded in 24-well plates overnight. The day
after, the medium was changed by fresh complete
medium which contained increasing concentrations
of A. ascalonicum (0, 25, 50, 100, 200 400, 600, 800,
1000, 1500, and 2000 ﾵg/ml). At 24, 48 and 72 h of
treatments, the cells were washed with PBS and
harvested. Trypan blue dye was further added to
the cell suspensions. The Trypan blue-staining cells
were examined as damaged or dead cells.
L LD DH H   c cy yt to ot to ox xi ic ci it ty y   a as ss sa ay y   
The cytotoxic effect of the aqueous extract of
A. ascalonicum was also examined using LDH assay
as  described  by  Linford  [19]  with  some
modifications. Briefly, the cell lines were separately
plated at a density of 5 ￗ 103 per well in 96-well
microplates  with  RPMI  1640-DMEM  medium
containing  10%  FBS,  and  allowed  to  incubate
overnight. After 24 h of early cell culture, the fresh
medium with extract at concentrations of (0, 25, 
50,  100,  200  400,  600,  800,  1000,  1500,  and 
2000 ﾵg/ml) was renewed. At 72 h of treatments,
the plates were centrifuged at 200 xg, and 100 ﾵl
of the media from each well was then transferred
to new 96-well plates. Thereafter, 100 ﾵl of LDH
assay mixture was added to each well and plates
were incubated at 37°C for 30 min. A group of wells
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was treated with 1% Triton X-100 solution for 
45 min to maximum LDH release. The LDH release
was estimated using a microplatereader at 495 nm
according to the manufacturer's instructions. Tests
were performed in triplicate. The mean cell viability
was expressed as a percentage of the control.
P Pr ro ol li if fe er ra at ti io on n   a as ss sa ay y
The cell lines were plated in 24-well plates at
a density of 5 ￗ 104 cells/well in complete medium
and  incubated  at  37°C under  a humidified
atmosphere containing 5% CO2 for 24 h. The day
after, the cells were treated with fresh medium
containing  10%  FBS  and  the  determined
concentrations of the extract (0, 25, 50, 100, 200,
400, 600, 800, 1000, 1500, and 2000 ﾵg/ml). After
72 h, the treated and untreated cells were removed
and counted against control wells using a Coulter
counter (KX-21 Sysmex Co). 
A Ac ce et ti ic c   a ac ci id d- -i in nd du uc ce ed d   v va as sc cu ul la ar r   p pe er rm me ea ab bi il li it ty y   
i in n   m mi ic ce e
For acetic acid-induced vascular permeability
test, the Whittle’s method [20] was used with
somewhat modifications. Briefly, one hour after 
oral  administration  of  the  aqueous  extract  of
A. ascalonicum (50-200 mg/kg), and Indomethacin
(INN) (5 mg/ml); 0.1 ml/10 g body weight of 1%
Evans blue solution was injected intravenously in
each mouse. Thirty minutes later, 0.1 ml/10 g body
weight of 0.7% acetic acid in saline was intra  -
peritoneally injected for 30 min. Following the
administration of acetic acid, the mice were killed
by cervical dislocation and after extravasation of
10 ml of saline into the peritoneal cavity then, the
washing solutions were collected in separated test
tubes. Concentrations of Evans blue leaked into 
the  peritoneal  cavities  were  measured  by  the
absorbance at 590 nm of the collected washing
solutions. The vascular permeability was repre  -
sented in terms of the absorbance (A590).
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
All  measurements  were  evaluated  statically
expressed as mean ± standard deviation. Results
were analyzed by one way ANOVA. Values of p < 0.05
were considered significant. All experiments were
performed in triplicate unless otherwise noted.
Results
C Cy yt to ot to ox xi ic ci it ty y   e ef ff fe ec ct ts s   o of f   t th he e   a aq qu ue eo ou us s   e ex xt tr ra ac ct t   
o of f   A Al ll li iu um m a as sc ca al lo on ni ic cu um m   o on n   c ca an nc ce er r   c ce el ll l   l li in ne es s   
a an nd d   n no or rm ma al l   c ce el ll l   l li in ne e   
In this study, we evaluated the effects of the
aqueous extract of A. ascalonicum on viability of 
the three cancer cell lines including K562, Wehi164
and Jurkat, and normal cell line (HUVEC) using
Trypan blue and LDH assays evaluation. On the
basis of obtained results, after 24, 48 and 72 h of
incubation, the extract significantly reduced the
viability of three cell lines at different concentrations
compared with the control group, and these effects
were stronger as time increased. On the other hand,
the studied cytotoxicity treatments resulted in
a dose and time-dependent manner. Furthermore,
the observed results from effective concentrations
of the extract were accompanied with differences
for various cancer cell lines. In fact, and based 
on  data  of  Figure  1,  the  cytotoxic  effects  of
A. ascalonicum  for  Wehi164  cell  line  were
considerably lower than those on K562 and Jurkat
cell lines. As shown in Figure 1, the extract inhibited
viability of K562 and Jurkat cell lines at 100 ﾵg/ml
significantly, while this effect for Wehi164 cell line
occurred at higher concentrations (400 ﾵg/ml). The
IC50 values of the A. ascalonicum extract (the
concentration required for a 50% viability inhibition)
for  each  cancer  cell  line  have  been  shown  in 
Table I. Furthermore, treatment of HUVECs as
normal cell lines with the aqueous extract of the
A. ascalonicum bulbs up to 1000 ﾵg/ml or even
higher  concentrations  for  72  h  showed  no
considerable cytotoxic effect on the HUVECs. In fact,
under the concentration of 1000 ﾵg/ml, there was
no significant difference in viability between the
test and control wells. The IC50 value of the extract
for growth inhibition of the cells was determined
above 1 mg/ml (Table I). The IC50 values of the
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F Fi ig gu ur re e   1 1. .   The cytotoxic effects of different con  -
centrations of the aqueous extract of A. ascalonicum
on K562, Jurkat and Wehi164, and HUVEC cell lines.
The viability percentage of cell lines was assayed
using Trypan blue 4% exclusion and LDH assays.
Each data shown are one representative example of
three  independent  experiments,  expressed  as
a percentage of control and standard deviations
were within 5% of all experimental values
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A. ascalonicum extract (the concentration required
for a 50% viability inhibition) for each cancer cell
line have also been shown in Table I.
A Aq qu ue eo ou us s   e ex xt tr ra ac ct t   o of f   A Al ll li iu um m   a as sc ca al lo on ni ic cu um m   
i in nd du uc ce ed d   s su up pp pr re es ss si io on n   o of f   c ca an nc ce er r   c ce el ll l   l li in ne es s   
p pr ro ol li if fe er ra at ti io on n   
The antiproliferative activity of the A. asca  -
lonicum extract  on  the  cancer  cell  lines  was
determined by the Coulter counter, the results of
which are shown in Figure 2. After treatment with 
25-200 ﾵg/ml and higher concentrations of the
extract for 72 h, the proliferation ratio of K562 and
Jurkat cell lines decreased gradually as compared
with controls. While, the extract could not inhibit
the proliferation of Wehi164 cell line significantly
at similar concentrations, unless they are higher
than  400  ﾵg/ml.  These  results  showed  that
A. ascalonicum inhibited the proliferation of all cell
lines in a dose-dependent manner. The GI50 values
of the A. ascalonicum extract (50% proliferation or
growth inhibition) tested in these cancer cells were
also different after 72 h treatment (Table I). Indeed,
K562  and  Jurkat  cells  showed  the  highest
susceptibility (GI50: 100 ﾵg/ml), and Wehi164 cells
displayed the lowest susceptibility to A. ascalonicum
with GI50 at 400 ﾵg/ml.
We also examined the effects of the aqueous
extract of A. ascalonicum on HUVECs proliferation.
As the results showed (Figure 2), the extract inhibits
proliferation  of  HUVECs  in  a dose-dependent
manner. At concentrations up to 50 ﾵg/ml the
extract did not significantly decrease the number
of cells, but at 100 µg/ml and at higher con  -
centrations, it potently inhibited proliferation of
HUVECs. Finally, the 50% proliferation inhibition
(IC50) of the aqueous extract of A. ascalonicum on
HUVECs was estimated at 400 ﾵg/ml. 
A An nt ti i- -i in nf fl la am mm ma at to or ry y   e ef ff fe ec ct t   
o of f   t th he e   A Al ll li iu um m a as sc ca al lo on ni ic cu um m   e ex xt tr ra ac ct t
In order to assess an anti-inflammatory activity
of the aqueous extract of A. ascalonicum, the acetic
acid-induced vascular permeability model was used.
In this regard, mediators of inflammation released
following stimulation, leads to dilation of arterioles
and venules and increased vascular permeability
[21]. The extract at the oral doses of 25, 50, 100 and
200  mg/kg  showed  an  inhibition  in  vascular
permeability and this activity was increasing in the
dose-dependent manner (Table II). On the other
hand, the A. ascalonicum extract at the oral doses
of 25, 50, 100 and 200 mg/kg showed an inhibition
of 10.2%, 21.4%, 38.3% and 80.1% in vascular
permeability  assay,  respectively.  In  turn,  the
Indomethacin (INN) could cause 35.4% inhibition
of  vascular  permeability  (Table  II).  From  this
C Ce el ll l   l li in ne e    G GI I5 50 0   [ [ﾵ ﾵg g/ /m ml l] ] I IC C5 50 0   [ [ﾵ ﾵg g/ /m ml l] ]
K562 100 ±10 100 ±8
Jurkat 100 ±12  100 ±10
Wehi164 400 ±8 400 ±6
HUVEC 400 ±5 1600 ±8
T Ta ab bl le e   I I. . IC50 and GI50 value data of the aqueous
extract of A. ascalonicum, for K562, Jurkat and
Wehi164, and HUVEC after 72 h of treatment
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G Gr ro ou up p D Do os se e   [ [m mg g/ /k kg g, ,   p p. .o o. .] ] A A5 59 90 0 I In nh hi ib bi it ti io on n   ( (% %) )
A. ascalonicum 50 2.56 ±0.14 10.2
100 2.24 ±0.18 21.4
200 1.76 ±0.14 38.3
400 0.57 ±0.11  80.1
INN 5 1.84 ±0.04 35.4
Control – 2.85 ±0.08 –
T Ta ab bl le e   I II I. .   Effect of the A. ascalonicum extract on acetic acid-induced vascular permeability in mice. The results are
expressed as mean ± S.E. of n = 5. Inhibition percentages were calculated regarding the control treated with saline
only. Indomethacin (INN) was chosen as a positive control. P < 0.05 compared with the control group
F Fi ig gu ur re e   2 2. .   Inhibition of cancer and normal cell lines
by the aqueous extract of A. ascalonicum after 72 h.
The cells were counted by the Coulter Counter
(Sysmex KX21). Each column represents mean ± S.E.
of three independent experiments 
*p < 0.04, compared with the control group
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observation,  it  is  assumed  that  an  anti-in  fla  -
mmatory activity of the A. ascalonicum extract
results  from  its  protection  on  the  release  of
inflammatory mediators at the first stage.
Discussion
Diet plays a major role in cancer etiology and
prevention. Although inconsistencies exist across
studies that have investigated the relationship
between  diet  and  cancer,  dietary  factors
undoubtedly influence cancer risk [22]. There is
increasing evidence that fruits and vegetables have
chemopreventive  properties  because  of  the
supplement  and  synergistic  effects  of  various
phytochemicals present in these nourishments
[23-26].
From the other point of view, herbs and spices are
generally considered safe and proved to be effective
against various human ailments and their medicinal
uses have increased gradually in many countries. In
this regard, to assess the anticancer properties of
plants  which  have  been  widely  consumed  in
a human diet, the use of vegetable extracts provide
an interesting approach, because these extracts
contain several bioactive molecules [27-29].
Allium ascalonicum is one of the important
Allium species commonly used in many Asian diets
and in traditional medicine since ancient times.
A lot of evidence also suggested that Allium genus
possesses anticancer properties as shown by their
ability to suppress tumor proliferation in vivo and
in vitro [30-32]. In spite of wide consumption of
A. ascalonicum, reports regarding its biological
effects are rarely compared to other Allium species
such as garlic and onion. A. ascalonicum is usually
known  for  hypocholesterolemic,  antimicrobial,
antidermatophytic, and anti-angiogenic properties
[5, 8, 33-36].
Allium ascalonicum has been also reported to
exhibit antioxidative and free radical scavenging
capacities. These properties appear to be related to
the high contents of flavone, sulfur-containing
compounds, and polyphenolic derivatives in the
bulb of A. ascalonicum. Furthermore, it is shown
that the antioxidant potential of A. ascalonicum
comparing several onion varieties and some garlic
preparations is more noticeable [7, 37].
Furthermore, researchers demonstrated that it
can be useful to protect against oxidant-induced
various illness conditions, including as an adjunct
therapy in patients suffering nephrotoxicity from
consuming CsA [38]. In previous studies, we could
show that A. ascalonicum exhibits significant anti-
angiogenic effects on in vitro, ex vivo and also in
vivo  assays  without  the  toxic  effect  on  the
endothelial cells. Finally, we have demonstrated that
heat and acid conditions had no effect on its anti-
angiogenic activity [18, 39]. 
The present study was performed to examine the
possible potential of the A. ascalonicum extract on
anticancer and anti-inflammatory activities. For this
purpose, we examined in vitro antiproliferative and
cytotoxic effects of the A.ascalonicum extract against
three well known cell lines including Wehi164, K562
and Jurkat and HUVEC as a normal cell line. The
findings showed that A. ascalonicum, which contains
many benefit phytochemicals; significantly affects
the viability of all of the cancer cell lines in different
IC50 values as shown in Table I.
To examine the influence of the aqueous extract
of A. ascalonicum on cancer cell proliferation further;
the  cells  were  treated  with  increasing  extract
concentrations for 72 h. The obtained data of
counting  by  a Coulter  counter  showed  that
A. ascalonicum  induced  inhibition  of  the  cell
proliferation, resulting in a considerable reduction
of cell growth with dose increasing against the
control group. The 50% inhibitory concentrations
of A. ascalonicum for the above-mentioned cell
lines, which significantly resulted in restraint of their
growth, were estimated (Table I). In agreement with
50%  inhibition  of  cell  proliferation  (the
concentration of the extract that is required for half-
maximal inhibition), the order of sensitivity of the
cell lines to extract was K562, Jurkat > Wehi164 with
GI50 of 100 and 400 ﾵg/ml, respectively (Table I).
Meanwhile,  the  results  showed  that  the
proliferation of HUVEC cells was inhibited by the
aqueous extract of A. ascalonicum with GI50 about
400 ﾵg/ml. In general, K562, Jurkat and Wehi164
cell lines exhibited both decreased viability and
proliferation in a dose- and time-dependent manner
under  experimental  conditions.  These  results
further support previous observations concerning
inhibition of cell proliferation by shallot on tumor
cell lines, which showed that treatment of HeLa and
MCF-7 cell lines with different concentrations of the
chloroformic extract of shallot resulted in decreased
growth in a dose-dependent manner [15]. Finally
and on the basis of this investigation, we found that
A. ascalonicum had significant antiproliferative
effects on Wehi164 representing solid, and K562
and Jurkat cell lines as soft tumor cell lines in
comparison with HUVECs as a normal cell. 
Inflammation is a healthful response to offense
or injury and an important part of innate immunity.
Although inflammation acts as an adaptive host
defense against infection or injury and is primarily
a self-limiting process, inadequate resolution of
inflammatory responses often leads to various
chronic ailments including cancer [40, 41]. On the
other side, chronic or recurrent acute inflammation,
as a result of infectious agents or other sources,
has potential promotional functions in each of
tumor  initiation,  progression,  invasion,  and
metastasis phases [42, 43]. Besides, most solid
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tumors are known to exhibit highly enhanced
vascular permeability, similar to or more than the
inflammatory tissues. Cancer and inflammatory
tissues have various common vascular mediators,
such  as  NO,  BK  and  PGs,  and  their  most
predominant  physiological  effect  is  vascular
permeability enhancement. Enhanced vascular
permeability of tumor and inflammatory tissue is
the  key  to  be  considered  for  future  drug
development for more selective targeting for the
desired tumors or inflammatory lesions, based on
enhanced permeability and retention (EPR) effect
using macromolecular drugs [44-46].
Acetic acid-induced vascular permeability causes
an immediate reaction which is lasting a long period
of time over 24 h and arrives to infiltration of fluid
rich in plasma proteins [20, 47, 48]. It is therefore
used as a well-characterized mouse model of acute
inflammation.  Thus,  inhibition  of  vascular
permeability is considered a major feature for the
suppression  of  the  exudative  phase  of  acute
inflammation [49]. In the present study, in the well-
known  in  vivo  acetic  acid-induced  vascular
permeability  model,  we  observed  that  the
A. ascalonicum extract  shows  significant  anti-
inflammatory activity at a dose-response correlation
with extract increasing concentrations. However,
the aqueous extract of A. ascalonicum at low doses
had  no  considerable  effects  on  prevention  of
vascular permeability of acetic acid; it showed
meaningful differences comparing the inhibitory
effect of INN as a common drug in treating the
inflammation status. These findings suggest that
the  significant  anti-inflammatory  activity  of
A. ascalonicum may be due to affecting membrane-
stabilization to reduce vascular permeability or
through  inhibition  of  various  inflammatory
mediators.
Regarding our and previous findings of beneficial
properties  of  A. ascalonicum,  particularly  for
prevention and treating of cancer and inflammation
situations, further studies are needed to clarify the
responsible  compounds  and  their  possible
mechanisms in this regard.  
In  conclusion,  the  aqueous  extract  of
A. ascalonicum bulbs had the most cytotoxic activity
on  cancer  cell  lines  Jurkat  and  K562  against
Wehi164 with lower cytotoxic preference. Treatment
of  HUVECs  with  the  aqueous  extract  of  the
A. ascalonicum bulbs up to 1000 ﾵg/ml or even
higher  concentrations  for  72  h  showed  no
considerable cytotoxic effect on the HUVECs but
the extract inhibits proliferation of HUVECs in
a dose-dependent manner. It is of interest that the
extract  of  this  plant  has  showed  much  less
cytotoxicity against the normal cell line, and, if this
also occurs in vivo, the use of this plant clinically
for the treatment of cancer patients would have
some scientific support. Moreover, because of anti-
inflammatory activity in vivo, it would be regarded
as an excellent candidate for the development of
an anti-inflammatory drug with fewer side effects,
which needs to be more investigated.
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